Literature DB >> 27771636

Polio Eradication and Endgame Plan - Victory within Grasp.

Manish Patel1, Lisa Menning, Pankaj Bhatnagar.   

Abstract

Since the launch of the Global Polio Eradication Initiative (GPEI) by the World Health Assembly (WHA) in 1988, the number of polio-endemic countries has decreased from 125 to 2 (Afghanistan and Pakistan). To secure the gains and to address the remaining challenges, the GPEI developed the Polio Eradication and Endgame Strategic Plan, 2013-2018 (the Plan), endorsed by all Member States at the WHA in May 2013. One of the major elements that distinguishes this Plan from previous GPEI strategies is the approach to ending all polioviruses, both wild and vaccine-derived. Overall, the Plan outlines four main objectives: (1) to stop all wild poliovirus (WPV) transmission; (2) to introduce inactivated polio vaccine (IPV), withdraw all oral polio vaccines (OPV), and strengthen immunization systems in countries with weak immunization systems and strong polio infrastructure; (3) to certify all regions as polio-free and safely contain all poliovirus stocks; (4) and to mainstream the investment in polio eradication to benefit other priority public health initiatives for years to come. Implementing the Plan and meeting the milestones in a timely manner will help to ensure that that the world remains permanently polio-free.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27771636

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  1 in total

1.  Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea.

Authors:  Olubukola T Idoko; Kinga K Smolen; Oghenebrume Wariri; Abdulazeez Imam; Casey P Shannon; Tida Dibassey; Joann Diray-Arce; Alansana Darboe; Julia Strandmark; Rym Ben-Othman; Oludare A Odumade; Kerry McEnaney; Nelly Amenyogbe; William S Pomat; Simon van Haren; Guzmán Sanchez-Schmitz; Ryan R Brinkman; Hanno Steen; Robert E W Hancock; Scott J Tebbutt; Peter C Richmond; Anita H J van den Biggelaar; Tobias R Kollmann; Ofer Levy; Al Ozonoff; Beate Kampmann
Journal:  Front Pediatr       Date:  2020-04-30       Impact factor: 3.418

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.